Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease
Phase 1
- Conditions
- Parkinson's Disease
- Interventions
- Biological: mesenchymal stem cells
- First Posted Date
- 2018-06-08
- Last Posted Date
- 2021-12-30
- Lead Sponsor
- Hebei Newtherapy BIo-Pharma technology Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT03550183
- Locations
- 🇨🇳
Hebei Newtherapy BIo-Pharma Technology Co., Ltd, Shijiazhuang, Hebei, China
© Copyright 2025. All Rights Reserved by MedPath